AdBio Partners
Overview
AdBio Partners, formerly known as Advent France Biotechnology, is a French venture capital firm established in 2016. The firm focuses on early-stage investments in the life sciences sector, particularly in therapeutics-oriented projects. AdBio Partners has made 22 European investments in France, Belgium, Spain, and Ireland, supporting companies in areas such as oncology, inflammation, neurology, infectious diseases, metabolic disorders, rare diseases, enabling technologies, and e-health. The firm's operational team is managed by Alain Huriez and Matthieu Coutet, who bring extensive scientific, medical, and operational expertise to the firm. AdBio Partners' unique strategy combines early-stage investments in promising enterprises with strong entrepreneurial support to foster company growth. The firm has developed strong relationships within the European innovation ecosystem, attracting international venture capital syndicates to its portfolio companies. This approach has enabled AdBio Partners to establish a significant presence in the European biotech industry. In September 2021, AdBio Partners closed its second fund, AFB Seed Fund II, with a first close at €86 million ($102 million). This fund aims to create, develop, and finance promising European life sciences start-ups, with the goal of selecting and financing two before the end of 2021. The firm's commitment to supporting innovative biotech ventures underscores its dedication to advancing the European biotech industry.
Investment Focus
- Focus on therapeutics-oriented projects
- Address unmet medical needs
- Early-stage companies in Europe
- Innovative life sciences projects
- Strong entrepreneurial teams
- Early-stage companies
Portfolio Companies
Reach AdBio Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about AdBio Partners
What sectors does AdBio Partners invest in?
AdBio Partners invests in Healthcare, Energy, FoodTech, Life Sciences, Digital Health and Pharmaceuticals, and is based in Paris 11, France. AdBio Partners is listed as a venture capital in the ConnectSafely investor database.
What stage does AdBio Partners invest at?
AdBio Partners backs companies at Pre-Seed, Seed, Early Stage, Series A and Series B.
Which regions does AdBio Partners invest in?
AdBio Partners invests across France, Spain, Ireland and Belgium.
Who are the partners at AdBio Partners?
Team members listed for AdBio Partners include Celine Cosnac (Chief Financial Officer) and Alain Huriez (Chairman & Managing Partner).
What companies has AdBio Partners invested in?
AdBio Partners's portfolio includes AndzonBio1 and AndzonBio2.
How do I contact AdBio Partners?
AdBio Partners's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
